dTDP-4-dehydrorhamnose 3,5-epimerase

BE0002506ProteinPseudomonas aeruginosa (strain ATCC 15692 / PAO1 / 1C / PRS 101 / LMG 12228)rmlC

Catalyzes the epimerization of the C3' and C5'positions of dTDP-6-deoxy-D-xylo-4-hexulose, forming dTDP-6-deoxy-L-lyxo-4-hexulose. It is acted on by 1 drug in DrugBank.

Gene name
rmlC
UniProtKB entry
Q9HU21Swiss-Prot
Residues / weight
181 residues · 20,766 Da
Also known as
5.1.3.13 · dTDP-4-keto-6-deoxyglucose 3,5-epimerase · dTDP-6-deoxy-D-xylo-4-hexulose 3,5-epimerase · dTDP-L-rhamnose synthase · Thymidine diphospho-4-keto-rhamnose 3,5-epimerase

Resolves to

Protein
UniProtQ9HU21UniProt nameRMLC_PSEAE
Gene
NCBI Gene879991
Pharmacology
KEGGpae:PA5164
Structure
PDB1RTVPDB2IXHPDB2IXI
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
4GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on dTDP-4-dehydrorhamnose 3,5-epimerase, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In